Modernatx, Inc.
Clinical trials sponsored by Modernatx, Inc., explained in plain language.
-
Moderna tests mRNA vaccine against common virus that can harm babies
⭐️ VACCINE ⭐️ TerminatedThis study tested whether Moderna's mRNA-1647 vaccine could prevent cytomegalovirus (CMV) infection in healthy young adults. The trial involved over 7,400 participants aged 16-40 who were at risk of exposure to young children. Researchers compared the vaccine to a placebo to see …
Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 03, 2026 14:42 UTC
-
Moderna infant COVID vaccine trial halted early
⭐️ VACCINE ⭐️ TerminatedThis study aimed to test the safety and effectiveness of Moderna's updated COVID-19 vaccine (mRNA-1273.214) in very young infants, aged 12 weeks to under 6 months. It planned to compare the babies' immune responses to those seen in adults from a previous study. However, the trial…
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 16, 2026 15:23 UTC